Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Leukemia · Hematopoetic Stem Cell Transplantation · Donor Lymphocyte Infusion · CAR T-Cell Therapy · Lymphoma · Cell Therapy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The University of Arizona, Tucson, Arizona, United States
Contact: Principal Investigator (Richard J Simpson, PhD)Contact: Principal Investigator (Emmanuel Katsanis, MD)Forrest L Baker, PhD (Sub-investigator)Michael D Seckeler, MD (Sub-investigator)